The onset of the COVID-19 pandemic revealed significant gaps in the United States'
pandemic and public health emergency response system. At the federal level, government …

Introduction Human species is confronting with a gigantic global COVID-19 pandemic.
Initially, it was observed in Wuhan, China, and the COVID-19 cases spread across the globe …

Pregnant women are generally excluded from clinical research over safety concerns.
However, demands to include them in clinical vaccine development have intensified after …

To date, extensive research has been conducted on vaccination against COVID-19 during
pregnancy to verify the safety and efficacy of the vaccines, despite the fact that pregnant …

Traditionally, there has been a reluctance to involve pregnant people in clinical trials due to
complex ethical issues surrounding the risk to unborn babies. However it is crucial that new …

Since its discovery in late 2019, the severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) has been estimated to be responsible for at least 769.3 million infections and over …

Purpose mRNA COVID‐19 vaccines are used in pregnant populations whether advertently
or inadvertently. However, evidence on the safety of these vaccines during pregnancy is …

Women's physiological changes in pregnancy and breastfeeding may alter the
pharmacokinetics and the pharmacodynamics of many drugs, resulting in potential risks to …

Pregnant women might have an increased risk of SARS-COV-2 infection. Although evidence
towards the efficacy and safety of COVID-19 is growing still there is room for improvement on …

Background The World Health Organization declared the COVID‐19 pandemic on 11 March
2020. Vaccine development and deployment were swiftly prioritised as a method to manage …